LV PHARMA HOLDING: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
LV PHARMA HOLDING
Largest movements
- Tangible fixed assets +€294,501
new in 2025: €294,501
- Financial fixed assets +€63,925
up €63,925 (+3.2%), from €2.0m to €2.1m
- Other debts -€528,523
down €528,523 (-72.2%), from €731,569 to €203,046
- Debts after one year +€467,353
up €467,353 (+39.6%), from €1.2m to €1.6m
of which Other amounts payable: +€312,944
- Profit (loss) carried forward +€367,774
up €367,774 (+4,877%), from €7,542 to €375,315
- Financial income +€300,000
new in 2025: €300,000
- Gross operating margin +€184,921
up €184,921 (+1,291%), from €14,319 to €199,240
- Financial charges +€62,578
up €62,578 (+1,279%), from €4,892 to €67,470
- Depreciation +€42,999
new in 2025: €42,999
- Taxes +€16,227
up €16,227 (+861%), from €1,885 to €18,112
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,088,930 | €2,435,731 | +€346,801 | +16.6% |
| Fixed assets | 21/28 | €2,006,869 | €2,365,295 | +€358,426 | +17.9% |
| Tangible fixed assets | 22/27 | - | €294,501 | +€294,501 | |
| Land and buildings | 22 | - | €294,501 | +€294,501 | |
| Financial fixed assets | 28 | €2,006,869 | €2,070,794 | +€63,925 | +3.2% |
| Current assets | 29/58 | €82,061 | €70,435 | -€11,626 | -14.2% |
| Amounts receivable within one year | 40/41 | €22,385 | €30,862 | +€8,477 | +37.9% |
| Trade receivables | 40 | €22,385 | €0 | -€22,385 | -100% |
| Other amounts receivable | 41 | - | €30,862 | +€30,862 | |
| Cash at bank and in hand | 54/58 | €59,676 | €37,524 | -€22,152 | -37.1% |
| Deferred charges and accrued income | 490/1 | - | €2,049 | +€2,049 | |
| Total equity and liabilities | 10/49 | €2,088,930 | €2,435,731 | +€346,801 | +16.6% |
| Equity | 10/15 | €82,542 | €450,315 | +€367,774 | +446% |
| Contributions | 10/11 | €75,000 | €75,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €7,542 | €375,315 | +€367,774 | +4,877% |
| Amounts payable | 17/49 | €2,006,388 | €1,985,415 | -€20,973 | -1.0% |
| Amounts payable after more than one year | 17 | €1,180,051 | €1,647,404 | +€467,353 | +39.6% |
| Financial debts | 170/4 | €1,180,051 | €1,334,460 | +€154,409 | +13.1% |
| Other amounts payable | 178/9 | - | €312,944 | +€312,944 | |
| Amounts payable within one year | 42/48 | €826,337 | €322,364 | -€503,973 | -61.0% |
| Current portion of amounts payable after more than one year | 42 | €87,769 | €105,151 | +€17,383 | +19.8% |
| Trade debts | 44 | €584 | €967 | +€382 | +65.4% |
| Suppliers | 440/4 | €584 | €967 | +€382 | +65.4% |
| Taxes, remuneration and social security | 45 | €6,415 | €13,200 | +€6,784 | +106% |
| Taxes | 450/3 | €6,415 | €13,200 | +€6,784 | +106% |
| Other amounts payable | 47/48 | €731,569 | €203,046 | -€528,523 | -72.2% |
| Accrued charges and deferred income | 492/3 | - | €15,647 | +€15,647 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €42,999 | +€42,999 | |
| Other operating charges | 640/8 | - | €2,052 | +€2,052 | |
| Gross operating margin | 9900 | €14,319 | €199,240 | +€184,921 | +1,291% |
| Operating profit (loss) | 9901 | €14,319 | €154,189 | +€139,870 | +977% |
| Financial income | 75/76B | - | €300,000 | +€300,000 | |
| Recurring financial income | 75 | - | €300,000 | +€300,000 | |
| Financial charges | 65/66B | €4,892 | €67,470 | +€62,578 | +1,279% |
| Recurring financial charges | 65 | €4,892 | €67,470 | +€62,578 | +1,279% |
| Profit (loss) for the period before taxes | 9903 | €9,427 | €386,719 | +€377,292 | +4,002% |
| Income taxes | 67/77 | €1,885 | €18,112 | +€16,227 | +861% |
| Profit (loss) for the period | 9904 | €7,542 | €368,607 | +€361,065 | +4,788% |
| Profit (loss) for the period to be appropriated | 9905 | €7,542 | €368,607 | +€361,065 | +4,788% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.